Pure Global AI
Disease / condition

Amyotrophic Lateral Sclerosis clinical trials

Free access to 476 studies10+ countriesUpdated daily105 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
476
Total trials
10+
Countries
10+
Sponsors
105
Recruiting
By phase
N/A218
Phase 2104
Phase 158
Early Phase 135
Phase 330
By status
Completed201
Recruiting105
Not yet recruit...48
Unknown40
Terminated23
Top countries
United States of America139
France42
China27
Italy19
Spain15
Top sponsors
Peking University ...18
University of Mich...8
Assistance Publiqu...8
Merit E. Cudkowicz...8
Knopp Biosciences8
Recent trials
Latest clinical trials for Amyotrophic Lateral Sclerosis
Patients' and Caregivers' Views of Multidimensional Care in Amyotropic Lateral Sclerosis in Germany
Technische Universität Dresden · Germany
NCT06418646Recruiting
Personalized Antisense Oligonucleotide Therapy for A Single Participant With CHCHD10 ALS
n-Lorem Foundation · United States of America
NCT06392126Recruitment ...
Phase
Phase 1/2
ALS Phase II Study of NX210c
Axoltis Pharma · France
NCT06365216Not yet recr...
Phase
Phase 2
Neural Stem Cell Treatment for Amyotrophic Lateral Sclerosis (STEMALS)
Casa Sollievo della Sofferenza... · Italy
NCT06344260Recruiting
Phase
Phase 2
Perception of Unpleasant Sensations During Study Procedures in ALS Patients
Istituto Auxologico Italiano · Italy
NCT06325865Recruiting
Nerve Growth Factor Encapsulated With 2-methacryloyloxyethyl Phosphorylcholine Nanocapsules in the Treatment of Amyotrophic Lateral Sclerosis
Beijing Tiantan Hospital
NCT06391645Not yet recr...
Phase
Phase 2/3
Ultra-high-caloric, Fatty Diet in ALS
University of Ulm · Germany
NCT06280079Not yet recr...
Evaluating Verbal Communication in Structured Interactions: Theoretical and Clinical Implications
Penn State University
NCT06266403Not yet recr...
A Study to Assess the Safety, Tolerability, and Pharmacology of Darifenacin in Patients With ALS
McGill University · Canada
NCT06249867Not yet recr...
Phase
Phase 2
DIAGALS: Relation Between Tar DNA Binding Protein(TDP)-43 et Nrf-2 in ALS: a Track to Improve Diagnosis and Prognosis of the Disease
University Hospital, Tours
NCT06230562Not yet recr...
Contralateral R1 in Amyotrophic Lateral Sclerosis
Hospices Civils de Lyon · France
NCT06206629Recruiting
Reinnervation and Neuromuscular Transmission in ALS
University of Aarhus · Denmark
NCT06219759Recruiting
Study in ALS With Abatacept & IL-2
The Methodist Hospital Researc... · United States of America
NCT06307301Recruitment ...
Phase
Phase 1
A Study of VRG50635 in Participants With Amyotrophic Lateral Sclerosis (ALS)
Verge Genomics · Canada,Netherlands
NCT06215755Recruiting
Phase
Phase 1
Holter of Movement in Patients With Amyotrophic Lateral Sclerosis.
Dr. Stéphanie Delstanche · Belgium
NCT06228001Recruiting
Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS
Mario Negri Institute for Phar...
NCT06126315Not yet recr...
Phase
Phase 2/3
Safety, Tolerability, and Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Amyotrophic Lateral Sclerosis (ALS) Patients With SOD1 Mutations
UniQure Biopharma B.V.
NCT06100276Not yet recr...
Phase
Phase 1/2
Development of Targeted RNA-Seq for Amyotrophic Lateral Sclerosis Diagnosis
Centre Hospitalier Universitai... · France
NCT06083584Not yet recr...
Pridopidine in Amyotrophic Lateral Sclerosis (EAP 2)
Prilenia
NCT06069934Available
Remote Home Assessment of Patients With Amyotrophic Lateral Sclerosis
King's College London · United Kingdom
NCT06046599Recruiting
About this profile

Access comprehensive clinical trial information for Amyotrophic Lateral Sclerosis through Pure Global AI's free database. This collection includes 476 clinical trials across multiple phases including N/A, Phase 2, Phase 1. Currently, 105 trials are actively recruiting participants.

Research for Amyotrophic Lateral Sclerosis is being conducted in United States of America, France, China and 7+ other countries. Leading sponsors include Peking University Third Hospital and University of Michigan. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 476 clinical trials studying Amyotrophic Lateral Sclerosis, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Peking University Third Hospital, University of Michigan, Assistance Publique - Hôpitaux de Paris, among others.